Navigation Links
Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance
Date:3/25/2011

MORRISVILLE, N.C., March 25, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd, a leading research-based contract manufacturer of advanced intermediates and API's to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent addition of Mr. Robert Andrews as Vice President of Quality Assurance as of March 1, 2011.

Mr. Andrews brings to the table over 18 years' experience in the pharmaceutical industry (early and late stage), in quality assurance and quality control. Prior to Asymchem, he worked for solid dosage softgel and softlet manufacturer Banner Pharmacaps, Inc. as a part of their Global Technical Support Management at a total of five plants worldwide. Additionally, Mr. Andrews has worked in many medical and pharmaceutical enterprises in positions such as Senior Consultant of Quality Management at TSI Health Sciences, Inc and Division Quality Manager at Pridecraft Enterprises.

In his previous role, while focusing on quality management and supervision, he handled twenty US FDA, NCDA and DEA Inspections. He has offered technical support and quality management to six API plants and seven solid dosage facilities located throughout China, establishing an experienced foundation for his work coming into Asymchem.

As Vice President of Quality Assurance, Mr. Andrews will have overall responsibility for Asymchem's quality assurance program and management, improving upon Asymchem's cGMP QA management system to align and communicate with customers closely on quality issues. In addition, Mr. Andrews will be responsible for organizing and implementing training with regards to GMP and quality management throughout Asymchem.

"I am very pleased to have Mr. Andrews on board to help strengthen and expand Asymchem's established Quality Assurance program," states Dr Hao Hong, CEO of Asymchem. "With his broad experience in the regulatory and pharmaceutical industry, and proven track record of quality management in API manufacturing, I am confident that our QA program will stay on course for continual improvement."

Asymchem is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SGS Robert Burek to Speak at Medical Device Standards Seminar March 24
2. Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
3. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
4. Uroplasty Announces Addition of Robert Kill to its Board of Directors
5. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
6. CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at The Marijuana Conference in New York City on Oct. 25 & 26
7. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
8. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
9. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
10. North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
11. Watson Promotes Robert Stewart to Executive Vice President, Global Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... grow in 2017-2023. Various reasons for growth of the ... higher incidences of chronic diseases, high recovery cost of ... services. Medical lifting sling refers to an assistive ... mobility. These slings connect to the lift and hold ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Groth Family ... Pasco and Richland, is initiating a charity drive to support the family of ... recent automobile collision. , On October 29th of this year, Cindy Hendrickson ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... celebrated its 10th anniversary with the grand opening of the Sober College Robert ... event spanned two days, December 2-3, and was attended by an overwhelming amount ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio , founder ... national #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer ... Gives Back initiative, and we’re very pleased with the participation in every ...
(Date:12/8/2016)... ... 2016 , ... With the increasing demand for dental implants, the National Association ... to inform dentists and patients about the safety issues related to dental restorations. According ... the U.S. is projected to reach $6.4 billion in 2018 with more than 30 ...
Breaking Medicine News(10 mins):